FT Options’s Bristol-Myers Squibb BMY Stock Holding History

FT Options’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	$1.02M	Buy	116,800 +60,300	+107%	+$3.52M	1.54%	21
2017 Q2	$290K	Buy	56,500 +21,900	+63%	+$1.19M	0.5%	45
2017 Q1	$230K	Buy	+34,600	New	+$1.9M	0.3%	71
2016 Q4	–	Sell	-232,500	Closed	-$49K	–	267
2016 Q3	$49K	Buy	232,500 +182,500	+365%	+$11.7M	0.04%	214
2016 Q2	$173K	Buy	50,000 +30,100	+151%	+$2.13M	0.15%	110
2016 Q1	$25K	Buy	+19,900	New	+$1.25M	0.03%	201

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FT Options's BMY Position: Q4 2016 in Review

FT Options sold out of Bristol-Myers Squibb (BMY) in Q4 2016, closing a stake of 73,537 shares — an estimated $3.96M sold.

FT Options first reported a position in BMY in Q2 2016 and held it in 2 quarters. The position peaked at $3.96M in Q3 2016. 1,601 funds tracked by Wall St. Rank hold BMY as of Q4 2016.

FT Options reported no remaining Bristol-Myers Squibb position as of Q4 2016 after selling out during the quarter.
FT Options sold 73,537 Bristol-Myers Squibb shares in Q4 2016, an estimated $3.96M.
FT Options first reported a position in Bristol-Myers Squibb in Q2 2016 and held it in 2 quarters.
FT Options's Bristol-Myers Squibb position peaked at $3.96M in Q3 2016.
1,601 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2016.

Based on FT Options's 13F filing for Q4 2016, filed 10 Feb 2017.